Abstract
Panic disorder (PD), is characterized by repeated PAs (i.e. abrupt surges of anxiety and fear accompanied by physical – e.g. pounding heart, sweating, trembling, etc. – and cognitive – e.g. fear of dying, fear of losing control, etc. – symptoms that usually reach their peak within 10 min), and major changes in behavior or persistent anxiety over having further attacks for at least 1 month. Since PD can be treated with psychotropic drugs and/or psychotherapy it has been commonly considered a mental disorder. However, recent evidence indicates that patients with PD exhibit subclinical anomalies in the respiratory, cardiac, and balance systems. In addition, apart from reducing panic symptoms, many antipanic pharmacotherapies (e.g. SSRIs) improve the functioning of the abovementioned systems. Therefore, some authors believe PAs may be real alarms arising from transient instability of homeostatic body functions. The idea PD is a mere psychiatric disease may be challenged by acknowledging a paramount role also to aberrant homeostatic functioning. This might pave the way to a more integrated approach of treating PD.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Association AP. Diagnostic and statistical manual of mental disorders. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
Amaral JM, Spadaro PT, Pereira VM, Silva AC, Nardi AE. The carbon dioxide challenge test in panic disorder: a systematic review of preclinical and clinical research. Rev Bras Psiquiatr. 2013;35(3):318–31. doi:10.1590/1516-4446-2012-1045.
Kessler RC, Petukhova M, Sampson NA, Zaslavsky AM, Wittchen HU. Twelve-month and lifetime prevalence and lifetime morbid risk of anxiety and mood disorders in the United States. Int J Methods Psychiatr Res. 2012;21(3):169–84. doi:10.1002/mpr.1359.
Goodwin RD, Faravelli C, Rosi S, Cosci F, Truglia E, de Graaf R, et al. The epidemiology of panic disorder and agoraphobia in Europe. Eur Neuropsychopharmacol. 2005;15(4):435–43. doi:10.1016/j.euroneuro.2005.04.006.
Klein DF. False suffocation alarms, spontaneous panics, and related conditions. An integrative hypothesis. Arch Gen Psychiatry. 1993;50(4):306–17.
Gorman JM, Liebowitz MR, Fyer AJ, Stein J. A neuroanatomical hypothesis for panic disorder. Am J Psychiatry. 1989;146(2):148–61.
Gorman JM, Kent JM, Sullivan GM, Coplan JD. Neuroanatomical hypothesis of panic disorder, revised. Am J Psychiatry. 2000;157(4):493–505.
Bouton ME, Mineka S, Barlow DH. A modern learning theory perspective on the etiology of panic disorder. Psychol Rev. 2001;108(1):4–32.
Clark DM, Salkovskis PM, Ost LG, Breitholtz E, Koehler KA, Westling BE, et al. Misinterpretation of body sensations in panic disorder. J Consult Clin Psychol. 1997;65(2):203–13.
Bellodi L, Perna G. The panic respiration connection. Milan, Italy: Medical Media; 1998.
Davidson Jr, Nutt D. Anxiety and respiration. In: Disorders eA, editor. Anxiety disorders. Oxford: Blackwell Science Ltd.; 2003.
Schruers K, Griez E. The effects of tianeptine or paroxetine on 35 % CO2 provoked panic in panic disorder. J Psychopharmacol. 2004;18(4):553–8. doi:10.1177/0269881104047283.
Briggs AC, Stretch DD, Brandon S. Subtyping of panic disorder by symptom profile. Br J Psychiatry. 1993;163:201–9.
Grassi M, Caldirola D, Vanni G, Guerriero G, Piccinni M, Valchera A, et al. Baseline respiratory parameters in panic disorder: a meta-analysis. J Affect Disord. 2013;146(2):158–73. doi:10.1016/j.jad.2012.08.034.
Grassi M, Caldirola D, Di Chiaro NV, Riva A, Dacco S, Pompili M, et al. Are respiratory abnormalities specific for panic disorder? A meta-analysis. Neuropsychobiology. 2014;70(1):52–60. doi:10.1159/000364830.
Cowley DS, Roy-Byrne PP. Hyperventilation and panic disorder. Am J Med. 1987;83(5):929–37.
van den Hout MA, Hoekstra R, Arntz A, Christiaanse M, Ranschaert W, Schouten E. Hyperventilation is not diagnostically specific to panic patients. Psychosom Med. 1992;54(2):182–91.
Griez E, Zandbergen J, Lousberg H, van den Hout M. Effects of low pulmonary CO2 on panic anxiety. Compr Psychiatry. 1988;29(5):490–7.
Gorman JM, Papp LA, Martinez J, Goetz RR, Hollander E, Liebowitz MR, et al. High-dose carbon dioxide challenge test in anxiety disorder patients. Biol Psychiatry. 1990;28(9):743–57.
Meuret AE, Rosenfield D, Wilhelm FH, Zhou E, Conrad A, Ritz T, et al. Do unexpected panic attacks occur spontaneously? Biol Psychiatry. 2011;70(10):985–91. doi:10.1016/j.biopsych.2011.05.027.
Goodwin RD, Pine DS. Respiratory disease and panic attacks among adults in the United States. Chest. 2002;122(2):645–50.
Perna G, Battaglia M, Garberi A, Arancio C, Bertani A, Bellodi L. Carbon dioxide/oxygen challenge test in panic disorder. Psychiatry Res. 1994;52(2):159–71.
Spinhoven P, Ros M, Westgeest A, Van der Does AJ. The prevalence of respiratory disorders in panic disorder, major depressive disorder and V-code patients. Behav Res Ther. 1994;32(6):647–9.
Niccolai V, van Duinen MA, Griez EJ. Respiratory patterns in panic disorder reviewed: a focus on biological challenge tests. Acta Psychiatr Scand. 2009;120(3):167–77. doi:10.1111/j.1600-0447.2009.01408.x.
Perna G, Caldirola D, Bellodi L. Panic disorder: from respiration to the homeostatic brain. Acta Neuropsychiatr. 2004;16:57–67.
Preter M, Klein DF. Panic, suffocation false alarms, separation anxiety and endogenous opioids. Prog Neuropsychopharmacol Biol Psychiatry. 2008;32(3):603–12. doi:10.1016/j.pnpbp.2007.07.029.
Feinstein JS, Buzza C, Hurlemann R, Follmer RL, Dahdaleh NS, Coryell WH, et al. Fear and panic in humans with bilateral amygdala damage. Nat Neurosci. 2013;16(3):270–2. doi:10.1038/nn.3323.
Preter M, Klein DF. Lifelong opioidergic vulnerability through early life separation: A recent extension of the false suffocation alarm theory of panic disorder. Neurosci Biobehav Rev. 2014;46:345–51. doi:10.1016/j.neubiorev.2014.03.025.
Faravelli C, Lo Sauro C, Godini L, Lelli L, Benni L, Pietrini F, et al. Childhood stressful events, HPA axis and anxiety disorders. World J Psychiatry. 2012;2(1):13–25. doi:10.5498/wjp.v2.i1.13.
Pine DS, Klein RG, Coplan JD, Papp LA, Hoven CW, Martinez J, et al. Differential carbon dioxide sensitivity in childhood anxiety disorders and nonill comparison group. Arch Gen Psychiatry. 2000;57(10):960–7.
Perna G, Cocchi S, Bertani A, Arancio C, Bellodi L. Sensitivity to 35 % CO2 in healthy first-degree relatives of patients with panic disorder. Am J Psychiatry. 1995;152(4):623–5.
Coryell W, Pine D, Fyer A, Klein D. Anxiety responses to CO2 inhalation in subjects at high-risk for panic disorder. J Affect Disord. 2006;92(1):63–70. doi:10.1016/j.jad.2005.12.045.
Caldirola D, Bellodi L, Caumo A, Migliarese G, Perna G. Approximate entropy of respiratory patterns in panic disorder. Am J Psychiatry. 2004;161(1):79–87.
Perna G, Bertani A, Caldirola D, Gabriele A, Cocchi S, Bellodi L. Antipanic drug modulation of 35 % CO2 hyperreactivity and short-term treatment outcome. J Clin Psychopharmacol. 2002;22(3):300–8.
Nardi AE. Panic disorder is closely associated with respiratory obstructive illnesses. Am J Respir Crit Care Med. 2009;179(3):256–7. doi:10.1164/ajrccm.179.3.256.
Homma I, Masaoka Y. Breathing rhythms and emotions. Exp Physiol. 2008;93(9):1011–21. doi:10.1113/expphysiol.2008.042424.
Munjack DJ, Brown RA, Cabe DD, McDowell DE, Baltazar PL. A naturalistic follow-up of panic patients after short-term pharmacologic treatment. J Clin Psychopharmacol. 1993;13(2):156–8.
Wilhelm FH, Gerlach AL, Roth WT. Slow recovery from voluntary hyperventilation in panic disorder. Psychosom Med. 2001;63(4):638–49.
Wilhelm FH, Gevirtz R, Roth WT. Respiratory dysregulation in anxiety, functional cardiac, and pain disorders. Assessment, phenomenology, and treatment. Behav Modif. 2001;25(4):513–45.
Putnam RW, Filosa JA, Ritucci NA. Cellular mechanisms involved in CO(2) and acid signaling in chemosensitive neurons. Am J Physiol Cell Physiol. 2004;287(6):C1493–526. doi:10.1152/ajpcell.00282.2004.
Bailey JE, Argyropoulos SV, Lightman SL, Nutt DJ. Does the brain noradrenaline network mediate the effects of the CO2 challenge? J Psychopharmacol. 2003;17(3):252–9.
Protopopescu X, Pan H, Tuescher O, Cloitre M, Goldstein M, Engelien A, et al. Increased brainstem volume in panic disorder: a voxel-based morphometric study. Neuroreport. 2006;17(4):361–3. doi:10.1097/01.wnr.0000203354.80438.1.
Perna G, Guerriero G, Brambilla P, Caldirola D. Panic and the brainstem: clues from neuroimaging studies. CNS Neurol Disord Drug Targets. 2014;13(6):1049–56.
Remmers JE. Central neuron control of breathing. In: Altose MD, Kawakami Y, editors. Control of breathing in health and disease (lung biology in health and disease). New York: Marcel Dekker; 1999.
Esquivel G, Schruers KR, Maddock RJ, Colasanti A, Griez EJ. Acids in the brain: a factor in panic? J Psychopharmacol. 2010;24(5):639–47. doi:10.1177/0269881109104847.
Horn EM, Waldrop TG. Suprapontine control of respiration. Respir Physiol. 1998;114(3):201–11.
Roncon CM, Biesdorf C, Santana RG, Zangrossi Jr H, Graeff FG, Audi EA. The panicolytic-like effect of fluoxetine in the elevated T-maze is mediated by serotonin-induced activation of endogenous opioids in the dorsal periaqueductal grey. J Psychopharmacol. 2012;26(4):525–31. doi:10.1177/0269881111434619.
Balaban CD, Thayer JF. Neurological bases for balance-anxiety links. J Anxiety Disord. 2001;15(1–2):53–79.
Maddock RJ. The lactic acid response to alkalosis in panic disorder: an integrative review. J Neuropsychiatry Clin Neurosci. 2001;13(1):22–34.
Knuts IJ, Cosci F, Esquivel G, Goossens L, van Duinen M, Bareman M, et al. Cigarette smoking and 35 % CO(2) induced panic in panic disorder patients. J Affect Disord. 2010;124(1-2):215–8. doi:10.1016/j.jad.2009.10.012.
Breslau N, Klein DF. Smoking and panic attacks: an epidemiologic investigation. Arch Gen Psychiatry. 1999;56(12):1141–7.
Caldirola D, Bellodi L, Cammino S, Perna G. Smoking and respiratory irregularity in panic disorder. Biol Psychiatry. 2004;56(6):393–8. doi:10.1016/j.biopsych.2004.06.013.
Abelson JL, Weg JG, Nesse RM, Curtis GC. Persistent respiratory irregularity in patients with panic disorder. Biol Psychiatry. 2001;49(7):588–95.
Ley R. The many faces of Pan: psychological and physiological differences among three types of panic attacks. Behav Res Ther. 1992;30(4):347–57.
Song HM, Kim JH, Heo JY, Yu BH. Clinical characteristics of the respiratory subtype in panic disorder patients. Psychiatry Investig. 2014;11(4):412–8. doi:10.4306/pi.2014.11.4.412.
Nardi AE, Valenca AM, Mezzasalma MA, Lopes FL, Nascimento I, Veras AB, et al. 35 % carbon dioxide and breath-holding challenge tests in panic disorder: a comparison with spontaneous panic attacks. Depress Anxiety. 2006;23(4):236–44. doi:10.1002/da.20165.
Meuret AE, White KS, Ritz T, Roth WT, Hofmann SG, Brown TA. Panic attack symptom dimensions and their relationship to illness characteristics in panic disorder. J Psychiatr Res. 2006;40(6):520–7. doi:10.1016/j.jpsychires.2005.09.006.
Roberson-Nay R, Latendresse SJ, Kendler KS. A latent class approach to the external validation of respiratory and non-respiratory panic subtypes. Psychol Med. 2012;42(3):461–74. doi:10.1017/S0033291711001425.
Soares-Filho GL, Machado S, Arias-Carrion O, Santulli G, Mesquita CT, Cosci F, et al. Myocardial perfusion imaging study of CO(2)-induced panic attack. Am J Cardiol. 2014;113(2):384–8. doi:10.1016/j.amjcard.2013.09.035.
Starcevic V, Berle D. Cognitive specificity of anxiety disorders: a review of selected key constructs. Depress Anxiety. 2006;23(2):51–61. doi:10.1002/da.20145.
Batelaan N, De Graaf R, Van Balkom A, Vollebergh W, Beekman A. Thresholds for health and thresholds for illness: panic disorder versus subthreshold panic disorder. Psychol Med. 2007;37(2):247–56. doi:10.1017/S0033291706009007.
Katon WJ. Chest pain, cardiac disease, and panic disorder. J Clin Psychiatry. 1990;51(Suppl):27–30. discussion 50–3.
Coryell W, Noyes Jr R, House JD. Mortality among outpatients with anxiety disorders. Am J Psychiatry. 1986;143(4):508–10.
Chignon JM, Lepine JP, Ades J. Panic disorder in cardiac outpatients. Am J Psychiatry. 1993;150(5):780–5.
Fleet R, Lavoie K, Beitman BD. Is panic disorder associated with coronary artery disease? A critical review of the literature. J Psychosom Res. 2000;48(4–5):347–56.
Jeejeebhoy FM, Dorian P, Newman DM. Panic disorder and the heart: a cardiology perspective. J Psychosom Res. 2000;48(4–5):393–403.
Huffman JC, Pollack MH. Predicting panic disorder among patients with chest pain: an analysis of the literature. Psychosomatics. 2003;44(3):222–36. doi:10.1176/appi.psy.44.3.222.
Lynch P, Galbraith KM. Panic in the emergency room. Can J Psychiatry. 2003;48(6):361–6.
Katerndahl D. Panic plaques: panic disorder & coronary artery disease in patients with chest pain. J Am Board Fam Pract. 2004;17(2):114–26.
Katerndahl DA. The association between panic disorder and coronary artery disease among primary care patients presenting with chest pain: an updated literature review. Prim Care Companion J Clin Psychiatry. 2008;10(4):276–85.
Katerndahl DA. Chest pain and its importance in patients with panic disorder: an updated literature review. Prim Care Companion J Clin Psychiatry. 2008;10(5):376–83.
Bunevicius A, Staniute M, Brozaitiene J, Pop VJ, Neverauskas J, Bunevicius R. Screening for anxiety disorders in patients with coronary artery disease. Health Qual Life Outcomes. 2013;11:37. doi:10.1186/1477-7525-11-37.
Frasure-Smith N, Lesperance F. Depression and anxiety as predictors of 2-year cardiac events in patients with stable coronary artery disease. Arch Gen Psychiatry. 2008;65(1):62–71. doi:10.1001/archgenpsychiatry.2007.4.
Parker GB, Owen CA, Brotchie HL, Hyett MP. The impact of differing anxiety disorders on outcome following an acute coronary syndrome: time to start worrying? Depress Anxiety. 2010;27(3):302–9. doi:10.1002/da.20602.
Todaro JF, Shen BJ, Raffa SD, Tilkemeier PL, Niaura R. Prevalence of anxiety disorders in men and women with established coronary heart disease. J Cardiopulm Rehabil Prev. 2007;27(2):86–91. doi:10.1097/01.HCR.0000265036.24157.e7.
Dammen T, Arnesen H, Ekeberg O, Friis S. Psychological factors, pain attribution and medical morbidity in chest-pain patients with and without coronary artery disease. Gen Hosp Psychiatry. 2004;26(6):463–9. doi:10.1016/j.genhosppsych.2004.08.004.
Grenier S, Potvin O, Hudon C, Boyer R, Preville M, Desjardins L, et al. Twelve-month prevalence and correlates of subthreshold and threshold anxiety in community-dwelling older adults with cardiovascular diseases. J Affect Disord. 2012;136(3):724–32. doi:10.1016/j.jad.2011.09.052.
Chen YH, Tsai SY, Lee HC, Lin HC. Increased risk of acute myocardial infarction for patients with panic disorder: a nationwide population-based study. Psychosom Med. 2009;71(7):798–804. doi:10.1097/PSY.0b013e3181ad55e3.
Gomez-Caminero A, Blumentals WA, Russo LJ, Brown RR, Castilla-Puentes R. Does panic disorder increase the risk of coronary heart disease? A cohort study of a national managed care database. Psychosom Med. 2005;67(5):688–91.
Alvarenga ME, Richards JC, Lambert G, Esler MD. Psychophysiological mechanisms in panic disorder: a correlative analysis of noradrenaline spillover, neuronal noradrenaline reuptake, power spectral analysis of heart rate variability, and psychological variables. Psychosom Med. 2006;68(1):8–16. doi:10.1097/01.psy.0000195872.00987.db.
Yapislar H, Aydogan S, Ozum U. Biological understanding of the cardiovascular risk associated with major depression and panic disorder is important. Int J Psychiatry Clin Pract. 2012;16(1):27–32. doi:10.3109/13651501.2011.620127.
Jakovljevic M, Reiner Z, Milicic D. Mental disorders, treatment response, mortality and serum cholesterol: a new holistic look at old data. Psychiatr Danub. 2007;19(4):270–81.
Hoge EA, Brandstetter K, Moshier S, Pollack MH, Wong KK, Simon NM. Broad spectrum of cytokine abnormalities in panic disorder and posttraumatic stress disorder. Depress Anxiety. 2009;26(5):447–55. doi:10.1002/da.20564.
Fleet R, Lesperance F, Arsenault A, Gregoire J, Lavoie K, Laurin C, et al. Myocardial perfusion study of panic attacks in patients with coronary artery disease. Am J Cardiol. 2005;96(8):1064–8. doi:10.1016/j.amjcard.2005.06.035.
Niccolai V, van Duinen MA, Griez EJ. Objective and subjective measures in recovery from a 35 % carbon dioxide challenge. Can J Psychiatry. 2008;53(11):737–44.
Guyenet PG, Stornetta RL, Abbott SB, Depuy SD, Fortuna MG, Kanbar R. Central CO2 chemoreception and integrated neural mechanisms of cardiovascular and respiratory control. J Appl Physiol. 2010;108(4):995–1002. doi:10.1152/japplphysiol.00712.2009.
Girotti LA, Crosatto JR, Messuti H, Kaski JC, Dyszel E, Rivas CA, et al. The hyperventilation test as a method for developing successful therapy in Prinzmetal’s angina. Am J Cardiol. 1982;49(4):834–41.
Fujii H, Yasue H, Okumura K, Matsuyama K, Morikami Y, Miyagi H, et al. Hyperventilation-induced simultaneous multivessel coronary spasm in patients with variant angina: an echocardiographic and arteriographic study. J Am Coll Cardiol. 1988;12(5):1184–92.
Yeragani VK, Pohl R, Jampala VC, Balon R, Ramesh C, Srinivasan K. Increased QT variability in patients with panic disorder and depression. Psychiatry Res. 2000;93(3):225–35.
Yeragani VK, Sobolewski E, Igel G, Johnson C, Jampala VC, Kay J, et al. Decreased heart-period variability in patients with panic disorder: a study of Holter ECG records. Psychiatry Res. 1998;78(1–2):89–99.
Yeragani VK, Pohl R, Berger R, Balon R, Ramesh C, Glitz D, et al. Decreased heart rate variability in panic disorder patients: a study of power-spectral analysis of heart rate. Psychiatry Res. 1993;46(1):89–103.
Molgaard H, Sorensen KE, Bjerregaard P. Attenuated 24-h heart rate variability in apparently healthy subjects, subsequently suffering sudden cardiac death. Clin Auton Res. 1991;1(3):233–7.
Bigger Jr JT, Fleiss JL, Rolnitzky LM, Steinman RC. Frequency domain measures of heart period variability to assess risk late after myocardial infarction. J Am Coll Cardiol. 1993;21(3):729–36.
Yeragani VK, Pohl R, Jampala VC, Balon R, Kay J, Igel G. Effect of posture and isoproterenol on beat-to-beat heart rate and QT variability. Neuropsychobiology. 2000;41(3):113–23. doi:26642.
Sullivan GM, Kent JM, Kleber M, Martinez JM, Yeragani VK, Gorman JM. Effects of hyperventilation on heart rate and QT variability in panic disorder pre- and post-treatment. Psychiatry Res. 2004;125(1):29–39. doi:10.1016/j.psychres.2003.10.002.
Atmaca M, Yavuzkir M, Izci F, Gurok MG, Adiyaman S. QT wave dispersion in patients with panic disorder. Neurosci Bull. 2012;28(3):247–52.
Yavuzkir M, Atmaca M, Dagli N, Balin M, Karaca I, Mermi O, et al. P-wave dispersion in panic disorder. Psychosom Med. 2007;69(4):344–7. doi:10.1097/PSY.0b013e3180616900.
Tomaselli GF, Beuckelmann DJ, Calkins HG, Berger RD, Kessler PD, Lawrence JH, et al. Sudden cardiac death in heart failure. The role of abnormal repolarization. Circulation. 1994;90(5):2534–9.
Manttari M, Oikarinen L, Manninen V, Viitasalo M. QT dispersion as a risk factor for sudden cardiac death and fatal myocardial infarction in a coronary risk population. Heart. 1997;78(3):268–72.
Dilaveris PE, Gialafos EJ, Andrikopoulos GK, Richter DJ, Papanikolaou V, Poralis K, et al. Clinical and electrocardiographic predictors of recurrent atrial fibrillation. Pacing Clin Electrophysiol. 2000;23(3):352–8.
Fisher AJ, Woodward SH. Cardiac stability at differing levels of temporal analysis in panic disorder, post-traumatic stress disorder, and healthy controls. Psychophysiology. 2014;51(1):80–7. doi:10.1111/psyp.12148.
Cosci F, Knuts IJ, Abrams K, Griez EJ, Schruers KR. Cigarette smoking and panic: a critical review of the literature. J Clin Psychiatry. 2010;71(5):606–15. doi:10.4088/JCP.08r04523blu.
Muotri RW, Bernik MA. Panic disorder and exercise avoidance. Rev Bras Psiquiatr. 2014;36(1):68–75. doi:10.1590/1516-4446-2012-1012.
Caldirola D, Namia C, Micieli W, Carminati C, Bellodi L, Perna G. Cardiorespiratory response to physical exercise and psychological variables in panic disorder. Rev Bras Psiquiatr. 2011;33(4):385–9.
Sardinha A, Araujo CG, Soares-Filho GL, Nardi AE. Anxiety, panic disorder and coronary artery disease: issues concerning physical exercise and cognitive behavioral therapy. Expert Rev Cardiovasc Ther. 2011;9(2):165–75. doi:10.1586/erc.10.170.
Furman JM, Redfern MS, Jacob RG. Vestibulo-ocular function in anxiety disorders. J Vestib Res. 2006;16(4–5):209–15.
Jacob RG. Panic disorder and the vestibular system. Psychiatr Clin North Am. 1988;11(2):361–74.
Mezzasalma MA, Mathias Kde V, Nascimento I, Valenca AM, Nardi AE. Imipramine for vestibular dysfunction in panic disorder: a prospective case series. Arq Neuropsiquiatr. 2011;69(2A):196–201.
Stambolieva K, Angov G. Balance control in quiet upright standing in patients with panic disorder. Eur Arch Otorhinolaryngol. 2010;267(11):1695–9. doi:10.1007/s00405-010-1303-2.
Teggi R, Caldirola D, Fabiano B, Recanati P, Bussi M. Rehabilitation after acute vestibular disorders. J Laryngol Otol. 2009;123(4):397–402. doi:10.1017/S0022215108002983.
Perna G, Dario A, Caldirola D, Stefania B, Cesarani A, Bellodi L. Panic disorder: the role of the balance system. J Psychiatr Res. 2001;35(5):279–86.
Staab JP, Ruckenstein MJ. Which comes first? Psychogenic dizziness versus otogenic anxiety. Laryngoscope. 2003;113(10):1714–8.
Furman JM, Jacob RG. A clinical taxonomy of dizziness and anxiety in the otoneurological setting. J Anxiety Disord. 2001;15(1–2):9–26.
Schuerger RJ, Balaban CD. Immunohistochemical demonstration of regionally selective projections from locus coeruleus to the vestibular nuclei in rats. Exp Brain Res. 1993;92(3):351–9.
Yates BJ, Goto T, Kerman I, Bolton PS. Responses of caudal medullary raphe neurons to natural vestibular stimulation. J Neurophysiol. 1993;70(3):938–46.
Licata F, Li Volsi G, Maugeri G, Santangelo F. Excitatory and inhibitory effects of 5-hydroxytryptamine on the firing rate of medial vestibular nucleus neurons in the rat. Neurosci Lett. 1993;154(1–2):195–8.
Balaban CD. Projections from the parabrachial nucleus to the vestibular nuclei: potential substrates for autonomic and limbic influences on vestibular responses. Brain Res. 2004;996(1):126–37.
Balaban CD. Vestibular nucleus projections to the parabrachial nucleus in rabbits: implications for vestibular influences on the autonomic nervous system. Exp Brain Res. 1996;108(3):367–81.
Balaban CD, Beryozkin G. Vestibular nucleus projections to nucleus tractus solitarius and the dorsal motor nucleus of the vagus nerve: potential substrates for vestibulo-autonomic interactions. Exp Brain Res. 1994;98(2):200–12.
Reilly S, Trifunovic R. Lateral parabrachial nucleus lesions in the rat: neophobia and conditioned taste aversion. Brain Res Bull. 2001;55(3):359–66.
Hayward LF, Felder RB. Lateral parabrachial nucleus modulates baroreflex regulation of sympathetic nerve activity. Am J Physiol. 1998;274(5 Pt 2):R1274–82.
Chamberlin NL, Saper CB. Topographic organization of respiratory responses to glutamate microstimulation of the parabrachial nucleus in the rat. J Neurosci. 1994;14(11 Pt 1):6500–10.
Huh YE, Kim JS. Bedside evaluation of dizzy patients. J Clin Neurol. 2013;9(4):203–13. doi:10.3988/jcn.2013.9.4.203.
Craig AD. How do you feel? Interoception: the sense of the physiological condition of the body. Nat Rev Neurosci. 2002;3(8):655–66. doi:10.1038/nrn894.
Craig AD. How do you feel—now? The anterior insula and human awareness. Nat Rev Neurosci. 2009;10(1):59–70. doi:10.1038/nrn2555.
Gauriau C, Bernard JF. Pain pathways and parabrachial circuits in the rat. Exp Physiol. 2002;87(2):251–8.
Zylka MJ. Nonpeptidergic circuits feel your pain. Neuron. 2005;47(6):771–2. doi:10.1016/j.neuron.2005.09.003.
Fanselow MS. Neural organization of the defensive behavior system responsible for fear. Psychon Bull Rev. 1994;1(4):429–38. doi:10.3758/BF03210947.
Balaban CD. Vestibular autonomic regulation (including motion sickness and the mechanism of vomiting). Curr Opin Neurol. 1999;12(1):29–33.
Berencsi A, Ishihara M, Imanaka K. The functional role of central and peripheral vision in the control of posture. Hum Mov Sci. 2005;24(5–6):689–709. doi:10.1016/j.humov.2005.10.014.
Balaban CD. Neural substrates linking balance control and anxiety. Physiol Behav. 2002;77(4–5):469–75.
Redfern MS, Yardley L, Bronstein AM. Visual influences on balance. J Anxiety Disord. 2001;15(1–2):81–94.
Szirmai A, Kisely M, Nagy G, Nedeczky Z, Szabados EM, Toth A. Panic disorder in otoneurological experience. Int Tinnitus J. 2005;11(1):77–80.
Jacob RG, Whitney SL, Detweiler-Shostak G, Furman JM. Vestibular rehabilitation for patients with agoraphobia and vestibular dysfunction: a pilot study. J Anxiety Disord. 2001;15(1–2):131–46.
Simon NM, Parker SW, Wernick-Robinson M, Oppenheimer JE, Hoge EA, Worthington JJ, et al. Fluoxetine for vestibular dysfunction and anxiety: a prospective pilot study. Psychosomatics. 2005;46(4):334–9. doi:10.1176/appi.psy.46.4.334.
Palazzo L, Clemente R, Bersani G. Disturbo di panico e stagionalità: ipotesi di una sottotipizzazione del disturbo sulla base del suo andamento stagionale. Giorn Ital Psicopat. 2005;11:235–6.
Lelliott P, Marks I, McNamee G, Tobena A. Onset of panic disorder with agoraphobia. Toward an integrated model. Arch Gen Psychiatry. 1989;46(11):1000–4.
Bossini L, Frank E, Campinoti G, Valdagno M, Caterini C, Castrogiovanni P, et al. Photosensitivity and panic-agoraphobic spectrum: a pilot study. Riv Psichiatr. 2013;48(2):108–12. doi:10.1708/1272.14034.
Kellner M, Wiedemann K, Zihl J. Illumination perception in photophobic patients suffering from panic disorder with agoraphobia. Acta Psychiatr Scand. 1997;96(1):72–4.
Bitsios P, Szabadi E, Bradshaw CM. The inhibition of the pupillary light reflex by the threat of an electric shock: a potential laboratory model of human anxiety. J Psychopharmacol. 1996;10(4):279–87. doi:10.1177/026988119601000404.
Bossini L, Fagiolini A, Valdagno M, Padula L, Hofkens T, Castrogiovanni P. Photosensitivity in panic disorder. Depress Anxiety. 2009;26(1):E34–6. doi:10.1002/da.20477.
Alici H, Ercan S, Bulbul F, Alici D, Alpak G, Davutoglu V. Circadian blood pressure variation in normotensive patients with panic disorder. Angiology. 2014;65(8):747–9. doi:10.1177/0003319713512172.
Nascimento I, de Melo-Neto VL, Valenca AM, Lops FL, Freire RC, Cassabian LA, et al. Antipanic drugs and pulmonary function in panic disorder patients. Rev Psiq Clín. 2009;36:123–9.
Olsson M, Annerbrink K, Bengtsson F, Hedner J, Eriksson E. Paroxetine influences respiration in rats: implications for the treatment of panic disorder. Eur Neuropsychopharmacol. 2004;14(1):29–37.
Tucker P, Adamson P, Miranda Jr R, Scarborough A, Williams D, Groff J, et al. Paroxetine increases heart rate variability in panic disorder. J Clin Psychopharmacol. 1997;17(5):370–6.
Perna G, Alpini D, Caldirola D, Raponi G, Cesarani A, Bellodi L. Serotonergic modulation of the balance system in panic disorder: an open study. Depress Anxiety. 2003;17(2):101–6. doi:10.1002/da.10092.
Meuret AE, Wilhelm FH, Ritz T, Roth WT. Feedback of end-tidal pCO2 as a therapeutic approach for panic disorder. J Psychiatr Res. 2008;42(7):560–8. doi:10.1016/j.jpsychires.2007.06.005.
Broocks A, Bandelow B, Pekrun G, George A, Meyer T, Bartmann U, et al. Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder. Am J Psychiatry. 1998;155(5):603–9.
Sanchez-Meca J, Rosa-Alcazar AI, Marin-Martinez F, Gomez-Conesa A. Psychological treatment of panic disorder with or without agoraphobia: a meta-analysis. Clin Psychol Rev. 2010;30(1):37–50. doi:10.1016/j.cpr.2009.08.011.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Perna, G., Iannone, G., Torti, T., Caldirola, D. (2016). Panic Disorder, Is It Really a Mental Disorder? From Body Functions to the Homeostatic Brain. In: Nardi, A., Freire, R. (eds) Panic Disorder. Springer, Cham. https://doi.org/10.1007/978-3-319-12538-1_4
Download citation
DOI: https://doi.org/10.1007/978-3-319-12538-1_4
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-12537-4
Online ISBN: 978-3-319-12538-1
eBook Packages: MedicineMedicine (R0)